NARA Discovery
Article Details
← Back to Search Results
Journal Article

Activation of the circAGFG1/miR-195-5p/PD-L1 axis induces lung injury in sepsis

Yang Bi; Rui Ding; Xinyan Liu; Yun He; Xukun Liu; Shouye Ma; Chaofan Wang; Zhongfa Zhang; Xuan Song
Human Cell · Vol. 38, Issue 5 · 2025

Abstract

Severe sepsis can escalate to acute lung injury (ALI), a critical condition with limited treatment options. Emerging research highlights the role of non-coding RNAs, including microRNAs (miRNAs) and circular RNAs (circRNAs), in regulating epithelial and immune cell responses in sepsis-induced ALI. This study delves into the circAGFG1/miR-195-5p/PD-L1 axis to elucidate its potential in this context. The conducted experiments using Th17 cells differentiated from CD4+ T cells isolated from human umbilical cord blood, co-cultured with transfected Calu-3 cells. The assessed cell viability, RNA, and protein expression levels under inflammatory stimuli. In addition, we collected bronchoalveolar lavage fluid and lung tissues from a cecal ligation and puncture mouse model. Quantification of RNA and protein expression of inflammatory and survival markers provided insights into the regulatory mechanisms involved. Peripheral blood samples from sepsis/ALI patients and healthy controls revealed that circAGFG1 expression is significantly downregulated, while miR-195-5p expression is upregulated in patients compared to healthy individuals. In both Calu-3 cells and induced Th17 cells, as well as in sepsis-induced ALI mouse models, the circAGFG1/miR-195-5p/PD-L1 axis was shown to regulate the expression of inflammatory cytokines, Th17 cell differentiation, and markers of epithelial cell survival. Results show the circAGFG1/miR-195-5p/PD-L1 axis plays a critical role in the pathogenesis of sepsis-induced ALI. Targeting this axis could present a novel therapeutic strategy for preventing ALI in sepsis and other conditions characterized by heightened lung inflammation. This research paves the way for new treatment approaches, offering hope for improved outcomes in patients suffering from severe sepsis and ALI. Graphical abstract

Bibliographic Information

JournalHuman Cell
PublisherSpringer
Publication Date2025-07-14
Publication Year2025
Volume38
Issue5
Document TypeJournal Article
eISSN1749-0774
DOI10.1007/s13577-025-01258-z

Access Information

NARA Access Coverage2002-01-01~Current
Journal Homepagehttps://www.springer.com/journal/13577
Publisher PageOpen Publisher Page
Full-text access depends on NARA's subscribed coverage and institutional access.